It’s a Friday morning in the outpatient pediatric clinic when a nurse on the phone with a patient’s mother says that the mother is on the city bus with her 2 daughters on their way to the clinic because the 6-year-old daughter has developed fatigue, body aches, fever, and vomiting since they returned from West Africa.
Between January 1 and October 31 of this year, the Centers for Disease Control and Prevention confirmed 603 cases of measles in 22 states—the highest number since 1994—marking a striking resurgence of a disease that was declared eliminated in the United States in 2001.
Pharmaceutical manufacturers got a better idea of the value of FDA’s Priority Review Vouchers (PRVs) recently after Gilead Sciences paid $125 million in cash for Knight Therapeutics’ Neglected Tropical Disease PRV.
Recognition of the importance of diagnosing and treating congenital cytomegalovirus (CMV) infection in children early is fueling the development of faster diagnostic techniques, perhaps most notably, real-time polymerase chain reaction (PCR) analysis.
Only 6% of hospitals in the United States are well prepared to receive Ebola patients, according to a recent survey of infection prevention experts by the Association for Professionals in Infection Control and Epidemiology.
The Centers for Disease Control and Prevention (CDC) reported that carbapenem-resistant enterobacteriaceae (CRE) has increased over the last decade and most cases of resistance are associated with healthcare exposures. To slow the dissemination of CRE infections, local and state health departments need to take the lead in prevention efforts, according to CDC’s Morbidity and Mortality Weekly Report released on March 5.